ProfileGDS5678 / 1441042_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 11% 11% 11% 11% 10% 11% 13% 11% 10% 11% 11% 11% 11% 11% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.295311
GSM967853U87-EV human glioblastoma xenograft - Control 22.2692811
GSM967854U87-EV human glioblastoma xenograft - Control 32.2704411
GSM967855U87-EV human glioblastoma xenograft - Control 42.2183711
GSM967856U87-EV human glioblastoma xenograft - Control 52.21110
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3251711
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3416913
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.2452811
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2336710
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.2512411
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2530611
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2390511
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2618411
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.2559411